Kopsky, David J.
van Eijk, Ruben P. A.
Warendorf, Janna K.
Keppel Hesselink, Jan M.
Notermans, Nicolette C.
Vrancken, Alexander F. J. E. http://orcid.org/0000-0003-4649-6534
Funding for this research was provided by:
Prinses Beatrix Spierfonds (W.OK19-02)
Dr. C.J. Vaillant Fonds
Article History
Received: 7 April 2021
Accepted: 30 September 2022
First Online: 22 October 2022
Declarations
:
: Ethical approval has been granted for this trial by the Institutional Review Board of the University Medical Center of Utrecht, the Netherlands (reference number: 20/383). Written, informed consent to participate will be obtained from all participants.
: On request, the model consent form and the patient information letter can be provided.
: DJK and JMKH are holders of two patent applications: Topical phenytoin for use in the treatment of peripheral neuropathic pain (WO2018106107); and Topical pharmaceutical composition containing phenytoin and a (co-)analgesic for the treatment of chronic pain (WO2018106108).